Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Additional Impact of Glucose Tolerance on Telomere Length in Persons With and Without Metabolic Syndrome in the Elderly Ukraine Population.

Frontiers in endocrinology

Khalangot MD, Krasnienkov DS, Chizhova VP, Korkushko OV, Shatilo VB, Kukharsky VM, Kravchenko VI, Kovtun VA, Guryanov VG, Vaiserman AM.
PMID: 30873125
Front Endocrinol (Lausanne). 2019 Feb 28;10:128. doi: 10.3389/fendo.2019.00128. eCollection 2019.

No abstract available.

Cite
Khalangot MD, Krasnienkov DS, Chizhova VP, et al. Additional Impact of Glucose Tolerance on Telomere Length in Persons With and Without Metabolic Syndrome in the Elderly Ukraine Population. Front Endocrinol (Lausanne). 2019;10:128doi: 10.3389/fendo.2019.00128.
Khalangot, M. D., Krasnienkov, D. S., Chizhova, V. P., Korkushko, O. V., Shatilo, V. B., Kukharsky, V. M., Kravchenko, V. I., Kovtun, V. A., Guryanov, V. G., & Vaiserman, A. M. (2019). Additional Impact of Glucose Tolerance on Telomere Length in Persons With and Without Metabolic Syndrome in the Elderly Ukraine Population. Frontiers in endocrinology, 10128. https://doi.org/10.3389/fendo.2019.00128
Khalangot, Mykola D, et al. "Additional Impact of Glucose Tolerance on Telomere Length in Persons With and Without Metabolic Syndrome in the Elderly Ukraine Population." Frontiers in endocrinology vol. 10 (2019): 128. doi: https://doi.org/10.3389/fendo.2019.00128
Khalangot MD, Krasnienkov DS, Chizhova VP, Korkushko OV, Shatilo VB, Kukharsky VM, Kravchenko VI, Kovtun VA, Guryanov VG, Vaiserman AM. Additional Impact of Glucose Tolerance on Telomere Length in Persons With and Without Metabolic Syndrome in the Elderly Ukraine Population. Front Endocrinol (Lausanne). 2019 Feb 28;10:128. doi: 10.3389/fendo.2019.00128. eCollection 2019. PMID: 30873125; PMCID: PMC6404635.
Copy Download .nbib Format: NLM
[The tetrapeptide pankragen forte efficiency in elderly people with prediabetic state].

Advances in gerontology = Uspekhi gerontologii

Korkushko OV, Chizhovа VP, Shatilo VB, Khavinson VK.
PMID: 28976155
Adv Gerontol. 2013;26(2):297-308.

The aim of this study was to investigate the effectiveness of tetrapeptide pankragen-forte in older people with prediabetic state. A total of 150 healthy people of different ages, including 39 young people (20-39 years), 42 people. middle-aged (40-59 years)...

Cite
Korkushko OV, Chizhovа VP, Shatilo VB, et al. [The tetrapeptide pankragen forte efficiency in elderly people with prediabetic state]. Adv Gerontol. 2013;26(2):297-308
Korkushko, O. V., Chizhovа, V. P., Shatilo, V. B., & Khavinson, V. K. (2013). [The tetrapeptide pankragen forte efficiency in elderly people with prediabetic state]. Advances in gerontology = Uspekhi gerontologii, 26(2), 297-308.
Korkushko, O V, et al. "[The tetrapeptide pankragen forte efficiency in elderly people with prediabetic state]." Advances in gerontology = Uspekhi gerontologii vol. 26,2 (2013): 297-308.
Korkushko OV, Chizhovа VP, Shatilo VB, Khavinson VK. [The tetrapeptide pankragen forte efficiency in elderly people with prediabetic state]. Adv Gerontol. 2013;26(2):297-308. Russian. PMID: 28976155.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries